Intensity Therapeutics, Inc.

Historical 13F Holders

Symbol
INTS
CUSIP
45828J103
All holders as of
Q4 2025
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Filings

13D/G Filers

Investors who own more than 5% of a class must file a Schedule 13D or 13G. Every filing for 45828J103 since 12/18/2024, newest first.

Filer % of Class Filed
Armistice Capital, LLC 13G/A Amendment 2
2.6% 8/14/2025
Event 6/30/2025
Sapient Capital LLC 13G/A Amendment 1 3.9% 7/9/2025
Event 6/30/2025
Armistice Capital, LLC 13G/A Amendment 1
5.8% 5/15/2025
Event 3/31/2025
Armistice Capital, LLC 13G
8.1% 2/14/2025
Event 12/31/2024
Sapient Capital LLC 13G 7.4% 12/30/2024
Event 3/31/2024

13F Holders by Quarter

Period Filings Shares, Excl. Options Value, Excl. Options
2025 Q4 36 4.02 M $1.63 M
2025 Q3 26 2.96 M $721 k
2025 Q2 28 1.98 M $607 k
2025 Q1 22 2.59 M $5.10 M
2024 Q4 21 2.72 M $4.79 M
2024 Q3 22 1.74 M $6.65 M
2024 Q2 26 1.68 M $8.23 M
2024 Q1 20 1.64 M $8.54 M
2023 Q4 19 513 k $4.39 M
2023 Q3 11 298 k $1.19 M
2023 Q2 3 28.6 k $170 k